Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective (original) (raw)

• Bye, M. R., Ewig, J. M. & Quittell, L. M. Cystic fibrosis. Lung 172, 251–270 (1994).
  Article CAS PubMed Google Scholar
• Boucher, R. C. Relationship of airway epithelial ion transport to chronic bronchitis. Proc. Am. Thorac. Soc. 1, 66–70 (2004).
  Article CAS PubMed Google Scholar
• Armstrong, D. S. et al. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 310, 1571–1572 (1995).
  Article CAS PubMed Central PubMed Google Scholar
• Armstrong, D. S. et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr. Pulmonol. 40, 500–510 (2005).
  Article PubMed Google Scholar
• Hoiby, N., Frederiksen, B. & Pressler, T. Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibros. 4, 49–54 (2005).
  Article CAS PubMed Google Scholar
• Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry 2010 annual data report (Cystic Fibrosis Foundation, 2011).
• Bjarnsholt, T. et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44, 547–558 (2009).
  Article PubMed Google Scholar
• Ulrich, M. et al. Alveolar inflammation in cystic fibrosis. J. Cyst. Fibros. 9, 217–227 (2010).
  Article CAS PubMed Central PubMed Google Scholar
• Yang, L., Jelsbak, L. & Molin, S. Microbial ecology and adaptation in cystic fibrosis airways. Environ. Microbiol. 13, 1682–1689 (2011).
  Article CAS PubMed Google Scholar
• Hansen, C. R., Pressler, T. & Hoiby, N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J. Cyst. Fibros. 7, 523–530 (2008).
  Article CAS PubMed Google Scholar
• Rasmussen, J. et al. CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. J. Cyst. Fibros. 11, 93–99 (2012).
  Article PubMed Google Scholar
• Harrison, F. Microbial ecology of the cystic fibrosis lung. Microbiology 153, 917–923 (2007).
  Article CAS PubMed Google Scholar
• Koch, C. Early infection and progression of cystic fibrosis lung disease. Pediatr. Pulmonol. 34, 232–236 (2002).
  Article PubMed Google Scholar
• Hoiby, N. & Johansen, H. K. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review? J. Hosp. Infect. 65, 374–375 (2007).
  Article CAS PubMed Google Scholar
• FitzSimmons, S. C. The changing epidemiology of cystic fibrosis. J. Pediatr. 122, 1–9 (1993).
  Article CAS PubMed Google Scholar
• Burns, J. L. et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183, 444–452 (2001).
  Article CAS PubMed Google Scholar
• Johansen, H. K. & Hoiby, N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47, 109–111 (1992).
  Article CAS PubMed Central PubMed Google Scholar
• Doring, G., Taccetti, G., Campana, S., Festini, F. & Mascherini, M. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients. Eur. Respir. J. 27, 653 (2006).
  Article CAS PubMed Google Scholar
• Gibson, R. L. et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 167, 841–849 (2003).
  Article PubMed Google Scholar
• Munck, A. et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr. Pulmonol. 32, 288–292 (2001).
  Article CAS PubMed Google Scholar
• Jelsbak, L. et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 75, 2214–2224 (2007).
  Article CAS PubMed Central PubMed Google Scholar
• Doring, G. et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur. Respir. J. 16, 749–767 (2000).
  Article CAS PubMed Google Scholar
• Doring, G. & Hoiby, N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J. Cyst. Fibros. 3, 67–91 (2004).
  Article PubMed Google Scholar
• Lee, T. W., Brownlee, K. G., Conway, S. P., Denton, M. & Littlewood, J. M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2, 29–34 (2003).
  Article PubMed Google Scholar
• Nichols, D., Chmiel, J. & Berger, M. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin. Rev. Allergy Immunol. 34, 146–162 (2008).
  Article CAS PubMed Google Scholar
• Regamey, N., Jeffery, P. K., Alton, E. W., Bush, A. & Davies, J. C. Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax 66, 624–629 (2011).
  Article PubMed Google Scholar
• Anderson, G. G., Moreau-Marquis, S., Stanton, B. A. & O'Toole, G. A. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect. Immun. 76, 1423–1433 (2008).
  Article CAS PubMed Central PubMed Google Scholar
• Aspedon, A., Palmer, K. & Whiteley, M. Microarray analysis of the osmotic stress response in Pseudomonas aeruginosa. J. Bacteriol. 188, 2721–2725 (2006).
  Article CAS PubMed Central PubMed Google Scholar
• Bagge, N. et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production. Antimicrob. Agents Chemother. 48, 1175–1187 (2004).
  Article CAS PubMed Central PubMed Google Scholar
• Cirz, R. T., O'Neill, B. M., Hammond, J. A., Head, S. R. & Romesberg, F. E. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J. Bacteriol. 188, 7101–7110 (2006).
  Article CAS PubMed Central PubMed Google Scholar
• Jones, A. K. et al. Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits cyclic AMP/Vfr signaling. J. Bacteriol. 192, 5709–5717 (2010).
  Article CAS PubMed Central PubMed Google Scholar
• Wu, W., Badrane, H., Arora, S., Baker, H. V. & Jin, S. MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa. J. Bacteriol. 186, 7575–7585 (2004).
  Article CAS PubMed Central PubMed Google Scholar
• Huse, H. K. et al. Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. mBio 1, e00199–10 (2010).
  Article PubMed Central CAS PubMed Google Scholar
• Rau, M. H. et al. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ. Microbiol. 12, 1643–1658 (2010).
  CAS PubMed Google Scholar
• Yang, L. et al. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl Acad. Sci. USA 108, 7481–7486 (2011). This report outlines the evolutionary dynamics of a transmissible P. aeruginosa clone (DK2) during 35 years of growth in a CF airway.
  Article CAS PubMed PubMed Central Google Scholar
• Hull, J., Vervaart, P., Grimwood, K. & Phelan, P. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 52, 557–560 (1997).
  Article CAS PubMed Central PubMed Google Scholar
• Hudson, A. L., Sotirchos, I. M., Davey, M. W. & Hudson, V. M. The activity and hydrogen peroxide sensitivity of the peroxiredoxins from the parasitic nematode Haemonchus contortus. Mol. Biochem. Parasitol. 176, 17–24 (2011).
  Article CAS PubMed Google Scholar
• Hudson, V. M. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic. Biol. Med. 30, 1440–1461 (2001).
  Article CAS PubMed Google Scholar
• Back, E. I. et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am. J. Clin. Nutr. 80, 374–384 (2004).
  Article CAS PubMed Google Scholar
• Worlitzsch, D. et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109, 317–325 (2002).
  Article CAS PubMed Central PubMed Google Scholar
• Kolpen, M. et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65, 57–62 (2010).
  Article CAS PubMed Google Scholar
• Hauser, A. R., Jain, M., Bar-Meir, M. & McColley, S. A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 24, 29–70 (2011).
  Article CAS PubMed Central PubMed Google Scholar
• Johansen, H. K. et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr. Pulmonol. 37, 427–432 (2004).
  Article PubMed Google Scholar
• Lister, P. D., Wolter, D. J. & Hanson, N. D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22, 582–610 (2009).
  Article CAS PubMed Central PubMed Google Scholar
• Bert, F., Branger, C. & Lambert-Zechovsky, N. Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J. Antimicrob. Chemother. 50, 11–18 (2002).
  Article CAS PubMed Google Scholar
• MacLeod, D. L. et al. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J. Infect. Dis. 181, 1180–1184 (2000).
  Article CAS PubMed Google Scholar
• Poole, K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49, 479–487 (2005).
  Article CAS PubMed Central PubMed Google Scholar
• Smith, E. E. et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl Acad. Sci. USA 103, 8487–8492 (2006). This paper describes the genomic analysis of longitudinal isolates of P. aeruginosa sampled from a young patient with CF, and provides a first insight into how this pathogen adapts to its human host.
  Article CAS PubMed PubMed Central Google Scholar
• Costerton, J. W., Irvin, R. T. & Cheng, K. J. The bacterial glycocalyx in nature and disease. Annu. Rev. Microbiol. 35, 299–324 (1981).
  Article CAS PubMed Google Scholar
• Cabral, D. A., Loh, B. A. & Speert, D. P. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Pediatr. Res. 22, 429–431 (1987).
  Article CAS PubMed Google Scholar
• Meshulam, T., Obedeanu, N., Merzbach, D. & Sobel, J. D. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa. Clin. Immunol. Immunopathol. 32, 151–165 (1984).
  Article CAS PubMed Google Scholar
• Meshulam, T., Verbrugh, H. A. & Verhoef, J. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains. Eur. J. Clin. Microbiol. 1, 112–117 (1982).
  Article CAS PubMed Google Scholar
• Simpson, J. A., Smith, S. E. & Dean, R. T. Scavenging by alginate of free radicals released by macrophages. Free Radic. Biol. Med. 6, 347–353 (1989).
  Article CAS PubMed Google Scholar
• Pedersen, S. S., Kharazmi, A., Espersen, F. & Hoiby, N. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect. Immun. 58, 3363–3368 (1990).
  CAS PubMed Central PubMed Google Scholar
• Govan, J. R. & Deretic, V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60, 539–574 (1996).
  CAS PubMed Central PubMed Google Scholar
• Pedersen, S. S. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl. 28, 1–79 (1992).
  CAS PubMed Google Scholar
• Martin, D. W. et al. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl Acad. Sci. USA 90, 8377–8381 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Boucher, J. C., Yu, H., Mudd, M. H. & Deretic, V. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect. Immun. 65, 3838–3846 (1997).
  CAS PubMed Central PubMed Google Scholar
• Wood, L. F. & Ohman, D. E. Identification of genes in the σ22 regulon of Pseudomonas aeruginosa required for cell envelope homeostasis in either the planktonic or the sessile mode of growth. mBio 3, e00094–12 (2012).
  Article CAS PubMed Central PubMed Google Scholar
• Ramsey, D. M. & Wozniak, D. J. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol. Microbiol. 56, 309–322 (2005).
  Article CAS PubMed Google Scholar
• Deretic, V., Schurr, M. J., Boucher, J. C. & Martin, D. W. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176, 2773–2780 (1994).
  Article CAS PubMed Central PubMed Google Scholar
• Chitnis, C. E. & Ohman, D. E. Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure. Mol. Microbiol. 8, 583–593 (1993).
  Article CAS PubMed Google Scholar
• DeVries, C. A. & Ohman, D. E. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J. Bacteriol. 176, 6677–6687 (1994).
  Article CAS PubMed Central PubMed Google Scholar
• Wood, L. F. & Ohman, D. E. Use of cell wall stress to characterize σ22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa. Mol. Microbiol. 72, 183–201 (2009).
  Article CAS PubMed Google Scholar
• Wood, L. F., Leech, A. J. & Ohman, D. E. Cell wall-inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: roles of σ22 (AlgT) and the AlgW and Prc proteases. Mol. Microbiol. 62, 412–426 (2006).
  Article CAS PubMed Google Scholar
• Ciofu, O., Fussing, V., Bagge, N., Koch, C. & Hoiby, N. Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, β-lactamase activity and RiboPrinting. J. Antimicrob. Chemother. 48, 391–396 (2001).
  Article CAS PubMed Google Scholar
• Gilligan, P. H. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4, 35–51 (1991).
  Article CAS PubMed Central PubMed Google Scholar
• Rainey, P. B. & Travisano, M. Adaptive radiation in a heterogeneous environment. Nature. 394, 69–72 (1998).
  Article CAS PubMed Google Scholar
• Mowat, E. et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 183, 1674–1679 (2011).
  Article PubMed Google Scholar
• Hansen, S. K. et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J. 6, 31–45 (2012).
  Article PubMed Google Scholar
• Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251–1254 (2000).
  Article CAS PubMed Google Scholar
• Hassett, D. J. et al. Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin. Ther. Targets 14, 117–130 (2010).
  Article CAS PubMed Google Scholar
• Fokkens, W. J. et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50, 1–12 (2012).
  Article PubMed Google Scholar
• Johansen, H. K. et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J. Cyst. Fibros. 15 May 2012 (doi:10.1016/j.jcf.2012.04.011).
  Article CAS PubMed Google Scholar
• Aanaes, K. et al. Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J. Cyst. Fibros. 10, 114–120 (2011).
  Article PubMed Google Scholar
• Robertson, J. M., Friedman, E. M. & Rubin, B. K. Nasal and sinus disease in cystic fibrosis. Paediatr. Respir. Rev. 9, 213–219 (2008).
  Article PubMed Google Scholar
• Mainz, J. G. et al. Concordant genotype of upper and lower airways P.aeruginosa and S.aureus isolates in cystic fibrosis. Thorax 64, 535–540 (2009).
  Article CAS PubMed Google Scholar
• Bonestroo, H. J., de Winter-de Groot, K. M., van der Ent, C. K. & Arets, H. G. Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. J. Cyst. Fibros. 9, 130–134 (2010).
  Article PubMed Google Scholar
• West, S. A., Griffin, A. S., Gardner, A. & Diggle, S. P. Social evolution theory for microorganisms. Nature Rev. Microbiol. 4, 597–607 (2006).
  Article CAS Google Scholar
• Hoffman, L. R. et al. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J. Cyst. Fibros. 8, 66–70 (2009).
  Article CAS PubMed Google Scholar
• D'Argenio, D. A. et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol. Microbiol. 64, 512–533 (2007).
  Article CAS PubMed Central PubMed Google Scholar
• Cramer, N. et al. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ. Microbiol. 13, 1690–1704 (2011).
  Article CAS PubMed Google Scholar
• Blount, Z. D., Borland, C. Z. & Lenski, R. E. Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli. Proc. Natl Acad. Sci. USA 105, 7899–7906 (2008).
  Article CAS PubMed Central PubMed Google Scholar
• Weinreich, D. M., Delaney, N. F., Depristo, M. A. & Hartl, D. L. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312, 111–114 (2006).
  CAS PubMed Google Scholar
• Woods, R. J. et al. Second-order selection for evolvability in a large Escherichia coli population. Science 331, 1433–1436 (2011).
  Article CAS PubMed Central PubMed Google Scholar
• Mahenthiralingam, E., Campbell, M. E., Foster, J., Lam, J. S. & Speert, D. P. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34, 1129–1135 (1996).
  CAS PubMed Central PubMed Google Scholar
• Romling, U. et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis. 170, 1616–1621 (1994).
  Article CAS PubMed Google Scholar
• Jelsbak, L. et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 75, 2214–2224 (2007).
  Article CAS PubMed Central PubMed Google Scholar
• Yang, L. et al. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190, 2767–2776 (2008).
  Article CAS PubMed Google Scholar
• Lieberman, T. D. et al. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nature Genet. 43, 1275–1280 (2011). This article provides an example of genomic evolution in a CF-associated pathogen.
  Article CAS PubMed Google Scholar
• Cramer, N., Wiehlmann, L. & Tummler, B. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis. Int. J. Med. Microbiol. 300, 526–533 (2010).
  Article PubMed Google Scholar
• Bragonzi, A. et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am. J. Respir. Crit. Care Med. 180, 138–145 (2009).
  Article PubMed Google Scholar
• Hoboth, C. et al. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 200, 118–130 (2009).
  Article CAS PubMed Google Scholar
• Hogardt, M. & Heesemann, J. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300, 557–562 (2010).
  Article CAS PubMed Google Scholar
• Barrick, J. E. et al. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461, 1243–1247 (2009). This work uses laboratory evolution experiments combined with genomic analysis to investigate evolution in action.
  Article CAS PubMed Google Scholar
• Cooper, V. S. & Lenski, R. E. The population genetics of ecological specialization in evolving Escherichia coli populations. Nature 407, 736–739 (2000).
  Article CAS PubMed Google Scholar
• Silander, O. K., Tenaillon, O. & Chao, L. Understanding the evolutionary fate of finite populations: the dynamics of mutational effects. PLoS Biol. 5, e94 (2007).
  Article PubMed Central CAS PubMed Google Scholar
• Holder, K. K. & Bull, J. J. Profiles of adaptation in two similar viruses. Genetics 159, 1393–1404 (2001).
  CAS PubMed Central PubMed Google Scholar
• Hansen, S. K. et al. Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6. J. Bacteriol. 189, 4932–4943 (2007).
  Article CAS PubMed Central PubMed Google Scholar
• Boles, B. R., Thoendel, M. & Singh, P. K. Self-generated diversity produces “insurance effects” in biofilm communities. Proc. Natl Acad. Sci. USA 101, 16630–16635 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Keymer, J. E., Galajda, P., Muldoon, C., Park, S. & Austin, R. H. Bacterial metapopulations in nanofabricated landscapes. Proc. Natl Acad. Sci. USA 103, 17290–17295 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Wilder, C. N., Allada, G. & Schuster, M. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect. Immun. 77, 5631–5639 (2009).
  Article CAS PubMed Central PubMed Google Scholar
• Hunter, P. The great leap forward. Major evolutionary jumps might be caused by changes in gene regulation rather than the emergence of new genes. EMBO Rep. 9, 608–611 (2008).
  Article CAS PubMed Central PubMed Google Scholar
• Wang, L. et al. Divergence involving global regulatory gene mutations in an Escherichia coli population evolving under phosphate limitation. Genome Biol. Evol. 2, 478–487 (2010).
  Article PubMed Central CAS PubMed Google Scholar
• Zambrano, M. M., Siegele, D. A., Almiron, M., Tormo, A. & Kolter, R. Microbial competition: Escherichia coli mutants that take over stationary phase cultures. Science 259, 1757–1760 (1993).
  Article CAS PubMed Google Scholar
• Conrad, T. M., Lewis, N. E. & Palsson, B. O. Microbial laboratory evolution in the era of genome-scale science. Mol. Syst. Biol. 7, 509 (2011).
  Article PubMed Central PubMed Google Scholar
• Sumby, P., Whitney, A. R., Graviss, E. A., DeLeo, F. R. & Musser, J. M. Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2, e5 (2006).
  Article PubMed Central CAS PubMed Google Scholar
• Giraud, A. et al. Dissecting the genetic components of adaptation of Escherichia coli to the mouse gut. PLoS Genet. 4, e2 (2008).
  Article PubMed Central CAS PubMed Google Scholar
• Kresse, A. U., Dinesh, S. D., Larbig, K. & Romling, U. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol. Microbiol. 47, 145–158 (2003).
  Article CAS PubMed Google Scholar
• Klockgether, J., Cramer, N., Wiehlmann, L., Davenport, C. F. & Tummler, B. Pseudomonas aeruginosa genomic structure and diversity. Front. Microbiol. 2, 150 (2011).
  Article CAS PubMed Central PubMed Google Scholar
• Hindre, T., Knibbe, C., Beslon, G. & Schneider, D. New insights into bacterial adaptation through in vivo and in silico experimental evolution. Nature Rev. Microbiol. 10, 352–365 (2012). This review describes how experimental evolution studies have provided fundamental insight into bacterial adaptive mechanisms.
  Article CAS Google Scholar
• Willner, D. et al. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J. 6, 471–474 (2012).
  Article CAS PubMed Google Scholar
• Zhao, J. et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl Acad. Sci. USA 109, 5809–5814 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Klepac-Ceraj, V. et al. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ. Microbiol. 12, 1293–1303 (2010).
  Article CAS PubMed Google Scholar
• Kleinstreuer, C., Zhang, Z. and Donohue, J. F. Targeted drug-aerosol delivery in the human respiratory system. Annu. Rev. Biomed. Eng. 10, 195–220 (2008).
  Article CAS PubMed Google Scholar
• Winnie, G. B. & Cowan, R. G. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function. Pediatr. Pulmonol. 10, 92–100 (1991).
  Article CAS PubMed Google Scholar
• Martin, D. W., Schurr, M. J., Yu, H. & Deretic, V. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to σE and stress response. J. Bacteriol. 176, 6688–6696 (1994).
  Article CAS PubMed Central PubMed Google Scholar